July 18, 2022 | Communications, Marketing, Pharmaceuticals, appointments, healthcare
Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.
Newcastle-based healthcare marketing communications agency Onyx Health has expanded its growing digital content team with the double appointment of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive. The latest additions to the team come off the back of a period of sustained growth, which has seen the agency expand its international client portfolio.
Onyx Health’s new digital content specialist Hope grew up in South Tyneside and holds a Business and Marketing Management degree from Sunderland University. She joins the Onyx Health team from Gateshead-based agency, Mediaworks, where she was a Content Strategist, working across multiple client accounts regionally and nationally. Prior to this, Hope worked for leading parent and baby brand, Tommee Tippee, as a Digital Marketing Manager and for Hebburn Sports Club as their Marketing Manager. She has expertise in branding, social media, SEO and PPC that she will bring to her new role with Onyx Health.
A Newcastle native, Jordan started his career as a Digital Media Apprentice at Newcastle University Students Union, before progressing to become a Marketing Assistant. In this role, he was responsible for the Student Union’s social media and creative content, which incorporated elements of video and creative design. One of Jordan’s proudest achievements in this role was seeing the videos he helped produce for Black History Month being used to help educate school children.
Commenting on the new appointments, Onyx Health’s Executive Director Trevor Pill said, “ Creating high quality digital content is an essential element of the creative communication campaigns that we develop and deliver for our clients.Our new appointments bring valuable digital content experience to the team, enabling us to develop and enhance our existing client offering. It’s been amazing to see our headcount grow from ten to thirty in the last two years. We’re very proud of the fact that our recruitment strategy continues to revolve around North-East talent. Its something that we hope to continue into the future.”
This content was provided by Onyx Health
Company Details
Latest Content from Onyx Health
Onyx Health’s Sarah Seilly discusses how innovative, data-driven approaches to medical education and strategic collaborations with HCPs can drive engagement and ensure commercial success in an evolving healthcare industry.
Onyx Health’s Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own
Amid the formidable challenges faced by the NHS, Onyx Health delve into the pivotal role of diagnostics in healthcare transformation, showcasing how collaboration, innovation, and patient-centric approaches are revolutionising healthcare…
Technological advancements are reshaping the healthcare industry. Onyx Health’s Medical Education Lead, Sarah Seilly, discusses the innovative techniques at the forefront of enhancing patient care.
Leading healthcare marketing communications agency, Onyx Health, has bolstered its team with the appointment of a new Head of Medical Education, Sarah Seilly. This strategic addition to the team reflects…
Newcastle-based creative agency Onyx Health has continued to grow and expand with the dual appointments of Rosie Thompson as Account Manager and Modupe Ayeni as a Medical Writer
MedTech company PolyPhotonix has had its innovative diabetes sleep mask adopted in the NHS for the first time
Onyx Health has announced the appointment of Trevor Pill as their new Managing Director. He will be taking over the day-to-day running of the agency from owner and founder Karen…
Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.
Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solutions.
